Rodrigo Huerta

Cooley advised Blue Owl Capital, a top asset manager redefining alternatives, on its strategic investment a $300 million royalty financing and a $450 million credit facility in BridgeBio Pharma, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers.

Cooley advised MadCap Software, a multichannel content authoring, management and publishing solutions provider, on its acquisition of Xyleme, which offers intelligent content management for the development, control, delivery, and syndication of vital proprietary learning and development content across the enterprise.

Cooley advised M33 Growth, a venture and growth-stage investment firm, on a series of strategic investments in:

• Operix (formerly IFS Core), a provider of software solutions for specialty contractors that allow for more efficient management of field operations personnel and processes through seamless integrations with core accounting platforms.
• PerformLine, a provider of a cloud-based, multichannel sales and marketing compliance platform for the banking, mortgage, insurance and financial services industries to monitor enterprise communication channels for regulatory and brand compliance and improve reporting and issue remediation workflows.
• Leading2Lean, a provider of a cloud-based digital workflow platform for discrete manufacturers that enables factories to implement more efficient production and maintenance processes.
• Yapi, a provider of a communication and patient engagement platform for dental offices that streamlines front office and marketing workflows, automates appointment reminders and digitizes paper-based forms such as patient consents.